Please select the option that best describes you:
What is your approach to using pegloticase in patients with congestive heart failure?
Answer from: at Academic Institution
Clinical trial data show developing CHF exacerbation in 2% of patients while on Pegloticase treatment, while real-world data show higher numbers (6.4%), so careful patient selection and stabilization of CHF are necessary before starting treatment, and need close monitoring while receiving treatment....
Sign In or Register to read more